Company / Cash per Share
BioNexus Gene Lab Corp Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.38
FY2025
5-year range
$0.01 / $1.38
FY2021-FY2025
Trend
+746.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +747% YoY in FY2025, a notable deviation from the 4-year average annual change of +511%.
Based on SEC 10-K filings.
1.38 in FY2025 with a 5-year CAGR of +119.5%.
Improved from $0.01 to $1.38 over the past 4 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +119.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 746.9% year-over-year.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.38 | +746.9% |
| FY2024 | $0.16 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.01 | -54.3% |
| FY2020 | $0.03 | +135.7% |
| FY2019 | $0.01 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026